Suven Pharma mulls inorganic push for its core business
Advertisement

Suven Pharma mulls inorganic push for its core business

By Sreeja Biswas

  • 11 Jul 2024
Premium
Suven Pharma mulls inorganic push for its core business
Annaswamy Vaidheesh, executive chairman, Suven Pharmaceuticals

Private equity giant Advent International-owned Suven Pharmaceuticals Ltd is scouting for acquisitions in the technology space to bolster its contract development and manufacturing organization (CDMO) platform, a top company executive told VCCircle. The Hyderabad-headquartered company, dealing in pharmaceuticals and fine chemical intermediates, is currently evaluating three to four companies in oligo ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement